The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index; 80 of the 128 sources its claims cite were checked for support.
Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials
Open accessAbstract
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of liver-related morbidity and mortality. Lifestyle interventions like the Mediterranean diet (MD) and exercise are recommended for management, but the most effective lifestyle approach remains unclear. METHODS: A comprehensive literature search was conducted in Embase, MEDLINE via Ovid, Cochrane Central, and Web of Science Core Collection from inception to April 1, 2025, without language restrictions. We included randomized controlled trials (RCTs) in adults with MASLD or metabolic dysfunction-associated steatohepatitis (MASH) assessing the MD and/or exercise interventions on anthropometric measures, liver enzymes, and indices or grades of liver steatosis and fibrosis. The mean difference and corresponding 95% confidence interval (CI) were pooled using a random-effects model. Risk of bias was assessed with ROB-2, and evidence certainty was evaluated using GRADE. RESULTS: , 95% CI = - 1.03 to - 0.36), waist circumference (WC) (WMD = - 1.56 cm, 95% CI - 3.02 to - 0.09), and alanine aminotransferase (ALT) (WMD = - 3.96 IU/L, 95% CI - 6.54 to - 1.38). Aerobic and combined aerobic-resistance exercises in comparison with the control group reduced body weight (WMD = - 1.56 kg, 95%CI - 2.31 to - 0.82; WMD = - 1.90 kg, 95%CI - 3.59 to - 0.22, respectively). In addition, aerobic exercise significantly decreased WC (WMD = - 2.14 IU/L, 95%CI - 2.87 to - 1.41) and resistance exercise reduced ALT (WMD = - 15.40 IU/L, 95%CI - 28.60 to - 2.20) in patients with MASLD/MASH compared to the control group. CONCLUSIONS: The MD and aerobic exercise, whether alone or combined with resistance training, support weight loss and improve liver health in patients with MASLD/MASH. Standardized methods for measuring and reporting outcomes are essential to build robust evidence on the impact of lifestyle changes on clinical outcomes. TRIAL REGISTRATION: PROSPERO registration code. CRD42024577846.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis of 37 RCTs found that Mediterranean diet and aerobic exercise, alone or combined with resistance training, support weight loss and some liver improvements in adults with MASLD/MASH. Evidence certainty was mostly low or very low, and the authors call for standardized outcome measurement and reporting.
Key findings
- Mediterranean diet vs control significantly reduced body weight (WMD = −2.38 kg, 95% CI −4.11 to −0.66), BMI (WMD = −0.70 kg/m², 95% CI −1.03 to −0.36), waist circumference (WMD = −1.56 cm, 95% CI −3.02 to −0.09), and ALT (WMD = −3.96 IU/L, 95% CI −6.54 to −1.38); AST and GGT did not change significantly.
- Aerobic exercise reduced body weight (WMD = −1.56 kg, 95% CI −2.31 to −0.82) and waist circumference (WMD = −2.14 IU/L, 95% CI −2.87 to −1.41, as reported); combined aerobic-resistance exercise reduced body weight (WMD = −1.90 kg, 95% CI −3.59 to −0.22); resistance exercise reduced ALT (WMD = −15.40 IU/L, 95% CI −28.60 to −2.20).
- Two RCTs assessed combined Mediterranean diet and exercise: one 6- and 12-month intervention reduced intrahepatic fat by MRI with no significant between-group differences; another found no significant between-group differences in BMI, waist circumference, or AST after 3 months, though CAP decreased in all groups.
- GRADE certainty was low for Mediterranean diet effects on weight, BMI, waist circumference, ALT, and GGT; very low for AST. For exercise, certainty ranged from moderate for aerobic exercise on GGT to low or very low for most other outcomes.
Methods
- Systematic review and meta-analysis following PRISMA, registered in PROSPERO (CRD42024577846). Searches covered Embase, MEDLINE via Ovid, Cochrane Central, and Web of Science Core Collection from inception to April 1, 2025, without language restrictions.
- Included RCTs in adults with MASLD/MASH assessing Mediterranean diet and/or exercise on anthropometric measures, liver enzymes, and liver steatosis or fibrosis indices/grades. From 4,806 search results, 37 unique RCTs were included: 11 Mediterranean diet, 27 exercise, and 2 combined Mediterranean diet plus exercise.
- Random-effects models pooled mean differences with 95% CIs; risk of bias was assessed with ROB-2 and certainty with GRADE. Exercise was categorized as aerobic, resistance, or combined aerobic-resistance, with HIIT grouped under combined; studies reporting geometric means were not pooled.
Limitations
- The authors state that lifestyle interventions were heterogeneous in design and implementation, with variability in exercise intensity, frequency, and adherence; blinding was not feasible; Mediterranean diet definitions and control groups varied widely; and many studies had small samples and short durations.
- The authors also note that several outcomes were supported by low or very low certainty evidence, limiting confidence in pooled estimates.
- Evident from the text: risk of bias was high in 12 exercise RCTs and 2 Mediterranean diet RCTs, with additional “some concerns” in many others, which further constrains interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
41 Valid · 8 Not valid · 17 Not checked · 39 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“The overall results showed that the MD significantly reduced weight [weighted mean difference (WMD = − 2.38 kg, 95% CI − 4.11 to − 0.66, P = 0.01) in comparison to standard care or control diet.”
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Results > Findings from systematic review and meta-analyses
What the sources say
- Not checked — no full text of the sourcecites [56] Properzi C, O’Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, et al. Ad libitum Mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial. Hepatology. 2018;68(5):1741–54. source
- Disputedcites [57] Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138–43. sourceExperimental — accuracy not yet measured
The Results report that weight loss was small and that the difference in weight change between the Mediterranean and comparison diets was not significant (p=0.1). The paper does not report the claimed weighted mean difference or confidence interval; its weight finding is contrary to the attributed significant reduction. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [59] Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, et al. Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients. 2017. https://doi.org/10.3390/nu9080870. sourceExperimental — accuracy not yet measured
The Results report significantly greater weight change in the Mediterranean-diet group than in the untreated control group (p = 0.0001). The paper does not report the claimed weighted mean difference of −2.38 kg, its 95% confidence interval, or p = 0.01; its Data Analysis section describes comparisons within this trial, not a pooled estimate. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“and WC [56–60, 62, 64] (WMD = − 1.56 cm, 95% CI = − 3.02 to − 0.09, P = 0.04) in comparison to standard care or control diet”
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Results > Findings from systematic review and meta-analyses
What the sources say
- Not checked — no full text of the sourcecites [56] Properzi C, O’Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, et al. Ad libitum Mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial. Hepatology. 2018;68(5):1741–54. source
- Disputedcites [57] Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138–43. sourceExperimental — accuracy not yet measured
The Results report no change in waist circumference between the Mediterranean and low-fat/high-carbohydrate diet periods, contrary to a significant reduction in this trial. The cited paper does not report the stated WMD; that figure appears to be a pooled estimate from the citing document. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [58] Curci R, Bianco A, Franco I, Bonfiglio C, Campanella A, Mirizzi A, et al. Lifestyle modification: evaluation of the effects of physical activity and low-glycemic-index Mediterranean diet on fibrosis score. Nutrients. 2023. https://doi.org/10.3390/nu15163520. sourceExperimental — accuracy not yet measured
Materials and Methods (sections 2.4 and 2.6) describe a trial comparing a low-glycemic-index Mediterranean diet with a control diet and measuring waist circumference. The Results (section 3) report effects on liver stiffness, but the passages in our copy do not establish a significant waist-circumference reduction or the quoted WMD, confidence interval, and P value; those appear to be the citing paper’s pooled estimates, not findings reported by this trial. (LLM, conf=0.84)
- Supportedcites [59] Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, et al. Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients. 2017. https://doi.org/10.3390/nu9080870. source
The Results report a significant reduction in waist circumference in the Mediterranean-diet group compared with the untreated control group (intergroup p = 0.0001). The WMD and confidence interval in the citing sentence are pooled estimates associated with several citations, not estimates attributed to this study alone. (LLM, conf=0.89)
- Partly supportedcites [60] Montemayor S, Bouzas C, Mascaró CM, Casares M, Llompart I, Abete I, et al. Effect of dietary and lifestyle interventions on the amelioration of NAFLD in patients with metabolic syndrome: the FLIPAN study. Nutrients. 2022. https://doi.org/10.3390/nu14112223. sourceExperimental — accuracy not yet measured
The Results report reduced waist circumference in both Mediterranean-diet groups, and the Conclusions say the high-meal-frequency group improved waist circumference compared with the control group. The paper does not report the cited WMD of −1.56 cm, its confidence interval, or P = 0.04; those are pooled estimates in the citing sentence, not this study’s results. (LLM, conf=0.85)
- Partly supportedcites [62] Ristic-Medic D, Kovacic M, Takic M, Arsic A, Petrovic S, Paunovic M, et al. Calorie-restricted Mediterranean and low-fat diets affect fatty acid status in individuals with nonalcoholic fatty liver disease. Nutrients. 2020;13(1): 15. sourceExperimental — accuracy not yet measured
The Results (page unavailable) report that waist circumference improved significantly from baseline after 12 weeks on either the Mediterranean or low-fat diet. The paper does not report a significant Mediterranean-diet advantage for waist circumference over the low-fat diet, nor the cited pooled estimate of −1.56 cm (95% CI −3.02 to −0.09). (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [64] Chooi YC, Zhang QA, Magkos F, Ng M, Michael N, Wu X, et al. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. Am J Clin Nutr. 2024;119(3):788–99. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“In total, seven studies reported data revealed that the MD significantly reduced BMI [56–60, 62, 64](WMD = − 0.70 kg/m2, 95% CI = − 1.03 to − 0.36, P < 0.001)”
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Results > Findings from systematic review and meta-analyses
What the sources say
- Not checked — no full text of the sourcecites [56] Properzi C, O’Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, et al. Ad libitum Mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial. Hepatology. 2018;68(5):1741–54. source
- Disputedcites [57] Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138–43. sourceExperimental — accuracy not yet measured
The Results section states that there was no change in BMI between the Mediterranean and comparison diet periods. It also reports that the difference in weight change was not significant. This trial therefore does not support a significant BMI reduction; the quoted WMD is a pooled estimate from seven studies, not a result reported by this paper. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [58] Curci R, Bianco A, Franco I, Bonfiglio C, Campanella A, Mirizzi A, et al. Lifestyle modification: evaluation of the effects of physical activity and low-glycemic-index Mediterranean diet on fibrosis score. Nutrients. 2023. https://doi.org/10.3390/nu15163520. sourceExperimental — accuracy not yet measured
The Methods describe a low-glycemic-index Mediterranean diet arm and a control-diet arm in a trial of people with NAFLD, and the Results report baseline BMI. The Results report significant reductions in liver stiffness (kPa), not a significant reduction in BMI. This paper therefore fits the group of studies cited, but our copy does not establish its contribution to the stated pooled BMI estimate. (LLM, conf=0.78)
- Supportedcites [59] Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, et al. Effect of Mediterranean diet and antioxidant formulation in non-alcoholic fatty liver disease: a randomized study. Nutrients. 2017. https://doi.org/10.3390/nu9080870. source
The Results report a significant difference in BMI change between the Mediterranean-diet-only group and the untreated control group (p = 0.0001). The WMD and confidence interval are the citing paper’s pooled estimate across seven studies, not a result attributed to this individual study. (LLM, conf=0.90)
- Supportedcites [60] Montemayor S, Bouzas C, Mascaró CM, Casares M, Llompart I, Abete I, et al. Effect of dietary and lifestyle interventions on the amelioration of NAFLD in patients with metabolic syndrome: the FLIPAN study. Nutrients. 2022. https://doi.org/10.3390/nu14112223. source
Methods (sections 2.3 and 2.5; page unavailable) describe a trial comparing two Mediterranean-diet interventions with a conventional diet and measuring BMI. Results (section 3; page unavailable) report BMI changes, so this paper fits the citing sentence’s identification of studies contributing BMI data. The quoted WMD is the citing authors’ pooled estimate, not an effect reported for this individual trial; this trial found no BMI difference between its groups. (LLM, conf=0.84)
- Partly supportedcites [62] Ristic-Medic D, Kovacic M, Takic M, Arsic A, Petrovic S, Paunovic M, et al. Calorie-restricted Mediterranean and low-fat diets affect fatty acid status in individuals with nonalcoholic fatty liver disease. Nutrients. 2020;13(1): 15. sourceExperimental — accuracy not yet measured
The Results report that BMI improved significantly from baseline after 12 weeks in both the Mediterranean- and low-fat-diet groups. This paper is relevant as a study contributing BMI data, but it does not report a significant between-diet BMI difference or the seven-study pooled WMD and confidence interval quoted in the citing sentence. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [64] Chooi YC, Zhang QA, Magkos F, Ng M, Michael N, Wu X, et al. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. Am J Clin Nutr. 2024;119(3):788–99. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Interventions on aerobic and aerobic-resistance combination showed weight reduction in comparison to control (WMD = − 1.56 kg, 95%CI − 2.31 to − 0.82, P < 0.001 and WMD = − 1.90 kg, 95%CI − 3.59 to − 0.22, P = 0.03, respectively).”
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Results > Findings from systematic review and meta-analyses
What the sources say
- Not checked yetcites [84] Aliniya N, Elmieh A, Fadaei Chafy M. The effect of combined training and Portulaca oleracea supplementation on plasma lipid profile and liver ultrasound in obese females with nonalcoholic fatty liver disease. J Arak Univ Med Sci. 2020;23(1):92–107. source
Checked before — its earlier verdict is held back until a new check runs.
- Disputedcites [85] Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, et al. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2017;15(1):96-102.e3. sourceExperimental — accuracy not yet measured
The Results section (“Body Mass Index, Body Composition, and Hepatic Triglyceride Content”; page not provided) states that weight remained constant in both groups, contrary to the claimed significant weight reduction versus control. The exercise program did combine aerobic and resistance training, but this paper does not report the attributed weight-loss result or WMD. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Not checked yetcites [86] Rajabi S, Askari R, Haghighi AH, Razavianzadeh N. The Effects of Two Different Intensities of Combined Training on C1q/TNF-Related Protein 3 (CTRP3) and Insulin Resistance in Women with Non-alcoholic Fatty Liver Disease. Hepat Mon. 2021;21. source
Checked before — its earlier verdict is held back until a new check runs.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Interventions on aerobic and aerobic-resistance combination showed weight reduction in comparison to control (WMD = − 1.56 kg, 95%CI − 2.31 to − 0.82, P < 0.001 and WMD = − 1.90 kg, 95%CI − 3.59 to − 0.22, P = 0.03, respectively).”
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Results > Findings from systematic review and meta-analyses
What the sources say
- Not checked yetcites [66] Astinchap A, Monazzami A, Fereidoonfara K, Rahimi Z, Rahimi M. Modulation of Fibroblast Growth Factor-21 and βklotho Proteins Expression in Type 2 DiabeticWomen with Non-alcoholic Fatty Liver Disease Following Endurance and Strength Training. Hepat Mon. 2021;21(7). source
Checked before — its earlier verdict is held back until a new check runs.
- Disputedcites [67] Cheng S, Ge J, Zhao C, Le S, Yang Y, Ke D, et al. Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: a randomized controlled trial. Sci Rep. 2017;7(1):15952. sourceExperimental — accuracy not yet measured
The Results > Intention to treat (ITT) analysis (page unavailable) says body weight changed in the intervention groups but found no significant group-by-time difference. It reports a significant body-weight difference versus no intervention only for exercise plus diet, not aerobic exercise alone. The paper also does not report the claimed −1.56 kg WMD or its confidence interval. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked yetcites [69] Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, Jones H, Pugh CJ, Richardson P, et al. Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. Clin Sci (Lond). 2016;130(2):93–104. source
Checked before — its earlier verdict is held back until a new check runs.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
60 more claims · 31 with their cited sources checked
Create a free account to see all 105 claims and to verify the 16 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 27
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Abstract > Results
“aerobic exercise significantly decreased WC (WMD = − 2.14 IU/L, 95%CI − 2.87 to − 1.41)”
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Results > Findings from systematic review and meta-analyses
“Nine aerobic interventions reported WC [69–72, 74, 75, 78, 79, 90], but no differences were found in comparison to control”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Regarding the RCTs on the MD, three were defined as “Low Risk” [56, 60]; seven studies were defined as “Some concerns” [28, 55, 57, 59, 61, 62, 64]; and two studies were defined as “High-Risk” [58, 63].”
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Results > Risk of bias and certainty of evidence
Reported 11 · recomputed 12
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Fifteen studies assessed only aerobic interventions [29, 66–79], four studies performed only resistance interventions [80–83], seven studies conducted combined aerobic-resistance [84–87] or HIIT [88, 89] interventions, and two studies assessed both aerobic and resistance as separate arms [90, 91].”
§ Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials > Results > Study characteristics
Reported 27 · recomputed 28
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
RoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100 · cited 1×
“Previously known as non-alcoholic fatty liver disease (NAFLD) [5], MASLD is a complex and heterogeneous condition characterized by abnormal hepatic fat accumulation unrelated to alcohol consumption or specific liver toxins [6, 7].”
Research works printed but not linked: 1
- Bayat Z, Gaeini A, Nuri R. Comparative effect of interval, continuous, and combined aerobic exercise on cardiovascular disease risk factors in type 2 diabetic patients with fatty liver. Pejouhesh dar Pezeshki (Research in Medicine). 2021;45(1):8–14.
Cited by
Paredes-Marin, A., He, Y., & Zhang, X. (2025) · Nutrients · doi:10.3390/nu17213491 · Cited by 17
Ma, C., Wang, J., Song, X., Wang, X., & Zong, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1682755 · Cited by 10
Chen, J., Wang, S., Xin, X., & Xie, J. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04517-3 · Cited by 8
Silent inflammation: a hidden cause of liver fibrosis
Schon, H.-T., & Weiskirchen, R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1676534 · Cited by 5
Xiang, S., Li, Y., Li, Y., Xie, S., Wang, C., Che, X., & Du, Y. (2026) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2026.100775 · Cited by 6
Metadata
- Authors
- Arita, V. A., Cabezas, M. C., Hernández Vargas, J. A., Trujillo-Cáceres, S. J., Mendez Pernicone, N., Bridge, L. A., Raeisi-Dehkordi, H., Dietvorst, C. A. W., Dekker, R., Uriza-Pinzón, J. P., Tawfik, M., Berk, K. A., Massoels, J., Driessen, S., Tushuizen, M. E., Holleboom, A. G., Grobbee, D. E., Franco, O. H., Beigrezaei, S., & GRIPonMASH Consortium
- Affiliations
- University Medical Center Utrecht (NL)
- Erasmus MC (NL)
- Novo Nordisk (Denmark) (DK)
- Echosens (France) (FR)
- Amsterdam University Medical Centers (NL)
- Leiden University Medical Center (NL)
- Corresponding author
- Beigrezaei, Sara
- ORCID
- Venue
- BMC Medicine
- Published
- 2025-08-27
- Volume
- 23
- Issue
- 1
- Pages
- 502-502
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC12392582
- OpenAlex
- W4413745403
- Cited by
- 43
- References
- 107
- Citations by year
- 2026: 38 · 2025: 5
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- BMC Medicine (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- Innovative Health Initiative Joint Undertaking (101132946)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- Mediterranean diet, physical activity, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, body composition, hepatic steatosis, liver fibrosis, aerobic exercise, resistance training, weight loss, waist circumference, alanine aminotransferase, lifestyle intervention, liver enzymes
- MeSH terms
- Body Composition, Fatty Liver, Humans, Liver, Exercise, Randomized Controlled Trials as Topic, Diet, Mediterranean
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1186/s12916-025-04320-7
- The paper
- Arita, V. A., Cabezas, M. C., Hernández Vargas, J. A., Trujillo-Cáceres, S. J., Mendez Pernicone, N., Bridge, L. A., Raeisi-Dehkordi, H., Dietvorst, C. A. W., Dekker, R., Uriza-Pinzón, J. P., Tawfik, M., Berk, K. A., Massoels, J., Driessen, S., Tushuizen, M. E., Holleboom, A. G., Grobbee, D. E., Franco, O. H., Beigrezaei, S., & GRIPonMASH Consortium. (2025). Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Medicine. https://doi.org/10.1186/s12916-025-04320-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
